A practical and clinically-grounded overview of the UK ADOPT (AI-enabled Detection of OsteoPorosis for Treatment) study...

The use of continuous glucose monitoring (CGM) by individuals with type 1 diabetes (T1D) has “revolutionised...

The Hadden Lecture was among the highlights of the Joint Irish-UK Endocrine Meeting. President of the...

The inaugural Joint Irish-UK Endocrine Meeting 2024 took place at the International Convention Centre in Belfast...

In this issue, national and international conference coverage, the top 10 unanswered questions in adults...

Joint Irish-UK Endocrine Meeting, Waterfront Centre, 14-15 October 2024

The HSE has launched an updated clinical guideline for type 1 diabetes and an updated model...

Obesity is described by the HSE as a chronic, complex, and progressive neuroendocrine disease, and is...

Diabetic retinopathy (DR) is the commonest microvascular complication of diabetes mellitus (DM). The retina is vulnerable...

Preliminary indications from ongoing Irish research are that patient preferences could play a significant role in...

A look at current and future pharmacology therapies for type 2 diabetes and pre-diabetes. Type 2...

Research. The winners of the awards at the Irish Endocrine Society (IES) Annual Meeting 2023 demonstrated...